Longer Survival May Come With a Cost in Melanoma – Curetoday.com
|
Longer Survival May Come With a Cost in Melanoma
Curetoday.com Immunotherapy showed improved survival benefits for stage 3 and 4 melanoma, but it came at a price of greater toxicity, according to a randomized, double-blind phase 3 study that compared 10 mg/kg Yervoy (ipilimumab) or a lower dose of the anti-CTLA-4 … |
